Mechanism of activation of an immunosuppressive drug: Azathioprine. Quantum chemical study on the reaction of azathioprine with cysteine

被引:31
作者
Hoffmann, M
Rychlewski, J
Chrzanowska, M
Hermann, T
机构
[1] Adam Mickiewicz Univ, Fac Chem, Quantum Chem Grp, PL-60780 Poznan, Poland
[2] Polish Acad Sci, Inst Bioorgan Chem, Poznan, Poland
[3] Poznan Univ Med Sci, Dept Phys Chem, PL-60781 Poznan, Poland
关键词
D O I
10.1021/ja010378c
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Azathioprine is an important drug used in the therapy of autoimmune disorders and in preventing graft rejection. Its molecule is composed of two main moieties: mercaptopurine and imidazole derivative, It is an immunosuppressive agent whose biological activity results from its in vivo mercaptolysis mediated by a nucleophilic attack on the C(5i) atom of imidazole ring of the azathioprine molecule. Solvation model SM5.4 with the PM3 Hamiltonian have been applied to model the reaction of azathioprine with cysteine. The employed quantum mechanical method shed new light on the mechanism of the reaction of azathioprine with cysteine in aqueous solution. The obtained results indicated that the first step in the reaction most likely involves the nucleophilic attack of the COO- of cysteine on the C(5i) atom of the imidazole ring of azathioprine, followed by a subsequent intramolecular attack of the SH group of the cysteine residue. It was shown that biogenic thiols such as glutathione or cysteine facilitate the first and crucial step of azathioprine metabolism, due to the presence of COO-, SH, and NH3+ groups in their molecules.
引用
收藏
页码:6404 / 6409
页数:6
相关论文
共 68 条
[1]   RADIATION SENSITIZATION AND CHEMOPOTENTIATION - RSU-1069, A COMPOUND MORE EFFICIENT THAN MISONIDAZOLE INVITRO AND INVIVO [J].
ADAMS, GE ;
AHMED, I ;
SHELDON, PW ;
STRATFORD, IJ .
BRITISH JOURNAL OF CANCER, 1984, 49 (05) :571-577
[2]  
ALWALL N, 1972, ACTA MED SCAND, V192, P455
[3]   A randomized trial comparing cyclosporine and steroids with cyclosporine, azathioprine, and steroids in cadaveric renal transplantation [J].
Amenábar, JJ ;
Gómez-Ullate, P ;
García-López, FJ ;
Aurrecoechea, B ;
García-Erauzkin, G ;
Lampreabe, I .
TRANSPLANTATION, 1998, 65 (05) :653-661
[4]   Azathioprine - Clinical pharmacology and current indications in autoimmune disorders [J].
Anstey, A ;
Lear, JT .
BIODRUGS, 1998, 9 (01) :33-47
[5]   THE INFLUENCE OF METRONIDAZOLE AND ITS 2 MAIN METABOLITES ON MURINE INVITRO LYMPHOCYTE-TRANSFORMATION [J].
BAHR, V ;
ULLMANN, U .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1983, 2 (06) :568-570
[6]   Monitored high-dose azathioprine treatment reduces acute rejection episodes after renal transplantation [J].
Bergan, S ;
Rugstad, IE ;
Bentdal, O ;
Sodal, G ;
Hartmann, A ;
Leivestad, T ;
Stokke, O .
TRANSPLANTATION, 1998, 66 (03) :334-339
[7]   A STUDY OF EFFECTS OF DRUGS IN PROLONGING SURVIVAL OF HOMOLOGOUS RENAL TRANSPLANTS IN DOGS [J].
CALNE, RY ;
ALEXANDRE, GPJ ;
MURRAY, JE .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1962, 99 (03) :743-+
[8]   CONVERSION OF AZATHIOPRINE INTO MERCAPROPURINE AND MERCAPTOIMIDAZOLE DERIVATIVES IN VITRO AND DURING IMMUNOSUPPRESSIVE THERAPY [J].
CHALMERS, AH ;
KNIGHT, PR ;
ATKINSON, MR .
AUSTRALIAN JOURNAL OF EXPERIMENTAL BIOLOGY AND MEDICAL SCIENCE, 1967, 45 :681-+
[9]   STUDIES ON MECHANISM OF FORMATION OF 5-MERCAPTO-1-METHYL-4-NITROIMIDAZOLE, A METABOLITE OF IMMUNOSUPPRESSIVE DRUG AZATHIOPRINE [J].
CHALMERS, AH .
BIOCHEMICAL PHARMACOLOGY, 1974, 23 (13) :1891-1901
[10]   Model for aqueous solvation based on class IV atomic charges and first solvation shell effects [J].
Chambers, CC ;
Hawkins, GD ;
Cramer, CJ ;
Truhlar, DG .
JOURNAL OF PHYSICAL CHEMISTRY, 1996, 100 (40) :16385-16398